To determine whether degrasyn‐induced anti‐cancer activity depends on the degradation of WT1 protein, pancreatic cancer cells were transduced with MSCV‐WT1 or MSCV‐NC followed by the treatment of degrasyn. This evidence concerns the gene WT1 and familial pancreatic carcinoma.